Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board
-
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
SES AI Announces its January 2026 Event Calendar
-
Proteris Compliance Solutions Launches Advanced Forms Management System
-
AE Industrial to Acquire Majority Stake in L3Harris’ Space Propulsion & Power Business – “Rocketdyne”
-
Rx Networks Partners with Zephr.xyz to Scale High-Precision GNSS for Mass-Market Android Devices
-
Stallion Uranium Announces Mobilization for Winter Drilling Program, Appoints Paulo Santos as Chief Financial Officer
-
Nanoscope Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
-
CareTrust Acquires Mid-Atlantic Skilled Nursing Portfolio for Approximately $142 Million
-
Continental Resources Expands Vaca Muerta Position Through Agreement With Pan American Energy
-
Laird Superfood® to Participate in 28th Annual ICR Conference on January 13, 2026
-
Natera Launches 21-Gene Fetal Focus™ Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP™ Technology
-
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion
-
COOLFLY to Debut the Aura Smart Bird Feeder at CES 2026
-
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Perion to Participate in the 28th Annual Needham Growth Conference on January 14th, 2026
-
L3Harris to Sell Majority Stake in Space Propulsion & Power Business to AE Industrial Partners
-
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
-
SBC Medical Accelerates Global Expansion with Strategic Investment and Alliance with a Leading U.S. MedSpa Platform OrangeTwist as Part of Broader Growth Strategy
-
Seeing Machines to unveil 3D Cabin Perception Mapping at CES2026
-
Comcast Announces Completion of Separation of Versant Media Group, Inc.
-
Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)
-
NaaS Technology Inc. to Hold Extraordinary General Meeting on January 23, 2026
-
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
ProtoArc to Debut Smart Workspace Concept at CES 2026
-
Cellarity to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Evergold Announces $300,000 Ore Group Financing, Sharpened Focus on Golden Lion Project, Toodoggone District, Northern BC
-
Sibros Launches SDV App Marketplace, Bringing Turnkey Connected Solutions to Automakers and Fleets
-
Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
-
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
-
Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.
-
IntBot to Debut First-Ever Unmanned CES Booth Run by a Robot; Humanoid "Nylo" Takes the Floor Solo
-
cliexa Announces cliexaAI – Opioid Use Disorder (OUD) Solution Is Now a Qualified Solution on Mayo Clinic Platform
-
CareTrust Announces Promotions and Key Hires
-
Majestic Steel USA Strengthens Executive Leadership, Naming Chad Broyles EVP of Business Operations
-
Zephr’s New Positioning SDK Brings Sub-Meter Precision to Android Devices – Laying the Groundwork for Location-Aware AI
-
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
ShipBob Surpasses 1 Billion Units Fulfilled, Sets New Black Friday/Cyber Monday Records as Brands Scale Across Channels
-
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morg
-
Everspin Technologies to Present at the Needham Growth Conference
-
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
-
MAYFLOWER WELCOMES BMS MOVING & STORAGE TO THE NETWORK, FURTHER STRENGTHENING ITS NATIONWIDE SERVICE
-
Mobilicom Announces New Design Win and Initial Order from United Arab Emirates–Based Arms Manufacturer
-
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
-
Mobix Labs Powers Up U.S. Defense Operations: Veteran Defense GM Takes the Helm; Bigger Military-Approved Facility Expansion Planned
-
Beamr 2026 Strategy and 2025 Highlights
-
UMH PROPERTIES, INC. FOURTH QUARTER AND FULL YEAR 2025 OPERATIONS UPDATE
